Trial Profile
A study of sofosbuvir- ledipasvir treatment on patients with HCV genotype 1b cirrhosis: The ital- c network study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Oct 2018
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 22 Oct 2018 New trial record